Bundamedik Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Agus Darjono

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure2.7yrs

Recent management updates

Recent updates


CEO

Agus Darjono

less than a year

Tenure

Mr. Agus Heru Darjono serves as Director at PT Diagnos Laboratorium Utama Tbk from September 2024. He is President Director of PT Bundamedik Tbk from May 30, 2024. He was President Director of PT Indofarma...


Board Members

NamePositionTenureCompensationOwnership
Agus Darjono
President Directorless than a yearno datano data
Emilia Simatupang
Director of Human Capital & Director2.9yrsno datano data
Sunata Tjiterosampurno
Commissioner2.4yrsno datano data
Mesha Sini
Commissionerless than a yearno data5.65%
IDR 116.7b
Ivan Sini
President Commissioner11.9yrsno data3.24%
IDR 66.9b
Wishnutama Kusubandio
Vice President Commissioner3.9yrsno datano data
Chairul Nasution
Independent Commissioner3.9yrsno datano data
Cuncun Wijaya Wibowo
Director2.4yrsno datano data

2.7yrs

Average Tenure

52yo

Average Age

Experienced Board: BMHS's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 08:38
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Bundamedik Tbk is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Lakshmi RowterCitigroup Inc
Erni SiahaanPT Ciptadana Securities
Robert SebastianPT Ciptadana Securities